Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bba842fc4d37dfcaced1b55bc0c91c7c |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44 |
filingDate |
1986-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9032ac4cf4aa66437c5d0fb9f87b5bb8 |
publicationDate |
1988-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
HU-195729-B |
titleOfInvention |
Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides |
abstract |
A controlled release formulation for oral administration comprising - a 9,10-dihydro ergot alkaloid, - a pharmaceutically acceptable hydrophilic swelling substance and - a pharmaceutically acceptable inert fatty material. The alkaloid may be co-dergocrine, dihydroergotamine, epicryptine or 9'-thia-9,10-dihydroergotamine. Suitable swelling agents are cellulose hydrocolloids such as hydropropyl-methylcellulose. The fatty material is preferably a fatty acid ester such as cetyl palmitate. The compositions are particularly useful in treating hypertension and migraine. |
priorityDate |
1985-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |